BioCentury
ARTICLE | Clinical News

Lemuteporfin: Phase I/II halted

August 4, 2008 7:00 AM UTC

QLT said it plans to halt development of lemuteporfin to treat acne after an interim review of data from a Phase I/II trial showed the product did not meet an internal therapeutic threshold. In 2006, ...